Skip to search formSkip to main contentSkip to account menu

Ancobon

Known as: Dermatech Brand of Flucytosine, Allphar Brand of Flucytosine, CSP Brand of Flucytosine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Local treatment as a treatment modality is gaining increased general acceptance over time. Novel drugs and methodologies of local… 
2007
2007
DERMATECH 2010 - Bildanalys inomdermatology. Visioner for medicinsk bildanalys i Ostergotland 
2004
2004
3168 Background: Cytosine deaminase, transferred into tumour cells by an adenovirus vector, can convert the antifungal drug… 
1996
1996
Fungus infections are becoming more important in surgical intensive medicine, and various preparations are now available to treat… 
Review
1992
Review
1992
Opportunistic fungus infections in neutropenic immunocompromised patients have strikingly increased, especially with the… 
1990
1990
A case report is presented of a 74 year old male with chronic bronchitis in whom fever, malaise and sputum hypersecretion was… 
1978
1978
Summary: The antifungal activity of Flucytosine (Ancobon®, Ancotil®) was tested against different pathogenic fungi. Five strains… 
1977
1977
Among the approved antimycotic remedies for the general treatment nystatin and amphotericin B of the group of polyenes… 
1976
1976
A widespread septicaemia with candida albicans, which occurs most commonly after excessive therapy with antibiotics and steroids…